Showing results (61-70 of 260) with videos related to
Sort By:
Pageof 26
British Journal of Haematology|August 22, 2003
All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cellsMohamad Mohty, Silvia Morbelli, Daniel Isnardon, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomasSamuel Troadec, Myriam Chentouf, Martine Cérutti, et al.Plos One|February 3, 2009
Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1Françoise Gondois-Rey, Clélia Dental, Philippe Halfon, et al.British Journal of Haematology|October 3, 2002
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitorsMohamad Mohty, Daniel Isnardon, Norbert Vey, et al.Frontiers in Immunology|September 20, 2021
Prognostic Gene Expression Signature in Patients With Distinct Glioma GradesSaadia Ait Ssi, Dounia Chraa, Khadija El Azhary, et al.Bulletin Du Cancer|November 12, 2003
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches]Mohamad Mohty, Béatrice Gaugler, Boris Calmels, et al.Journal of Medical Virology|April 14, 2012
Two years outcome of women infected with high risk HPV having normal colposcopy following low-grade or equivocal cytological abnormalities: are HPV16 and 18 viral load clinically useful predictive markers?Xavier Carcopino, Mireille Henry, Julien Mancini, et al.European Journal of Immunology|June 24, 2004
The SH3 domain of Tec kinase is essential for its targeting to activated CD28 costimulatory moleculeFabien Garçon, Marguerite Ghiotto, Audrey Gérard, et al.Plos One|September 18, 2009
Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functionsBérengère Vire, Stéphane de Walque, Audrey Restouin, et al.Blood|September 15, 2007
PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphomaLudivine Leseux, Guy Laurent, Camille Laurent, et al.Pageof 26